Aeneas Capital and Pyrinas Target Launch of US$120m Fund to Develop Co-Working Laboratory Ecosystems for Life Sciences Start-Ups in the United States
Aptorum Group Limited - Class A Ordinary Shares (APM)
Company Research
Source: Business Wire
HONG KONG--(BUSINESS WIRE)-- Aeneas Capital and Pyrinas, both affiliated companies to Aptorum Group Ltd (Nasdaq: APM), is launching its flagship fund - Pyrinas US Healthcare Real Estate Fund 1 SP – to acquire and develop co-working space and incubator facilities for the life sciences sector in the United States; Opportunity to invest in one of the most vibrant real estate sectors in the U.S. that is currently not available in most of the Asia Pacific countries. A great geographical and asset class diversification of Asia Pacific real estate investment; Tap into the life sciences sector that generally has one of the highest barriers to entry amongst different industries; Experienced and unique advisory/management team in this specific sector with established operation track record. Aeneas Capital Limited (“ACL”) and Pyrinas Real Est
Show less
Read more
Impact Snapshot
Event Time:
APM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
APM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
APM alerts
High impacting Aptorum Group Limited - Class A Ordinary Shares news events
Weekly update
A roundup of the hottest topics
APM
News
- Aptorum Group (NASDAQ:APM) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference [Yahoo! Finance]Yahoo! Finance
- DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2025 ConferenceGlobeNewswire
- Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering [Yahoo! Finance]Yahoo! Finance
- Aptorum Group Limited Announces Up To $6 Million Registered Direct OfferingGlobeNewswire
APM
Sec Filings
- 12/4/25 - Form EFFECT
- 11/18/25 - Form DEL
- 11/17/25 - Form F-1
- APM's page on the SEC website